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Tuberculosis (TB) remains one of the most important opportunistic 
infections among HIV-infected patients. Diagnosing pulmonary 
TB (PTB) has become problematic because HIV-positive patients 
tend to be smear negative and smear microscopy is the first line of 
diagnosis in people suspected to have TB.1 It is estimated that more 
than 50% of HIV-infected patients will develop TB in their lifetime, 
and the annual risk of developing TB if HIV infected is 10%.2 Various 
studies have shown high mortality rates in HIV-infected TB patients 
in resource-limited settings.2  HIV infection increases the risk of 
acquiring TB, alters the clinical presentation of TB and reduces 
overall survival.3,4 High mortality rates in these patients have been 
attributed to severe immunosuppression as measured by CD4+ cell 
count, and to lack of antiretroviral therapy (ART).5
One of the major challenges in resource-limited settings is clinical 
identification of HIV-infected TB patients who have sufficiently low 
CD4+ cell counts to merit early initiation of ART without the aid of 
expensive and not readily available CD4+ cell count tests. Being able 
to predict who might have a low CD4+ cell count would assist in the 
prioritisation of TB patients for ART and thus prevent initiation of 
ART when it is not yet indicated, an important advantage given that 
ART is a lifelong commitment. 
Materials and methods
A prospective cohort study was done on consecutive consenting 
participants  presenting at Beatrice Road Infectious Disease Hospital 
(BRIDH), Harare, Zimbabwe, and meeting the following inclusion 
criteria: age 18 years and over, HIV positive, sputum smear positive 
for acid-fast bacilli (AFB), and naïve to both ART and TB treatment. 
Patients with symptoms and signs suggestive of PTB were asked to 
produce two sputum specimens (one spot and an early-morning 
sample) for AFB microscopic examination using the Ziehl-Neelsen 
(ZN) staining technique.  Participants with positive smears for AFB 
were offered HIV testing and counselling. HIV tests were done using 
the Determine (Abbott Laboratories; sensitivity 100%, specificity 
98.60%) and Capillus (Trinity Biotech, Ireland; sensitivity 97.8%, 
specificity 99.7%) rapid test kits. Baseline laboratory tests including 
a CD4 cell count (Partec Cyflow SL3) and full blood count (Sysmex 
KF21) were done.
Socio-demographic data, medical history and the findings on 
physical examination were recorded using a standardised data collection 
tool. The baseline body mass index (BMI, kg/m2) and Karnofsky 
Performance Status (KPS) score were determined at enrolment.  
A sample size of 80 at 95% confidence interval (CI) was calculated 
using Epi Info version 6, assuming a population of 10 000 TB cases 
per year. Data were analysed using STATA version 8 (College Station, 
Tex., USA).  
Baseline characteristics were reported as means (standard deviation, 
SD) or medians (intraquartile range, IQR). Univariate and multivariate 
analyses were conducted to determine clinical predictors of a low CD4 
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Objectives. The study aimed to determine the clinical and laboratory 
predictors of a low CD4+ cell count (<200 cells/µl) in HIV-infected 
patients with pulmonary tuberculosis (PTB).
Design and setting. A prospective cohort study on HIV-positive 
patients with smear-positive PTB attending an outpatient clinic in 
Zimbabwe.
Participants. Consecutively consenting HIV-positive adults, aged 
18 years and over, who had positive sputum smears for acid-fast 
bacilli and were naïve to both antituberculosis drugs and ART.
Interventions. Baseline CD4+ cell count, full blood count, 
functional status using the Karnofsky Performance Status (KPS) 
score and body mass index (BMI, kg/m2) were determined for all 
participants. Univariate and multiple logistic regression analyses of 
the data were done. 
Results. Of the 97 participants recruited, 59 (61%) were females. 
The overall mean age was 34 years (standard deviation (SD) 8). The 
median CD4+ cell count was 104.5 cells/µl (intraquartile range (IQR) 
41 - 213 cells/µl). Patients with pleuritic chest pain were less likely to 
have a low CD4+ cell count than patients who did not (odds ratio 
(OR) 0.2; confidence interval (CI) 0.03 - 0.8). The following were 
statistically significant predictors of a CD4+ cell count of <200 cells/
µl: BMI <18 kg/m2 (OR 3.8; CI 1.2 - 12), KPS <54.4 (OR 3; CI 1.1 - 12) 
and haemoglobin concentration <8 g/dl (OR 13; CI 1.8 - 533). 
Conclusions. HIV-infected sputum-positive PTB patients presenting 
with a BMI <18, KPS <54.4% and haemoglobin concentration <8 g/dl 
should have early initiation of ART since they are more likely to have 
a low CD4+ cell count, whereas those presenting with pleuritic pain 
are less likely to have a low CD4+ cell count.   
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cell count (<200 cells/µl). The participants were stratified into two 
groups on the basis of their CD4 cell count (<200 and ≥200 cells/µl). 
The groups were compared using chi-square testing. Most variables 
were reported as odds ratios (OR) with 95% confidence intervals (CI). 
The study was approved by the Medical Research Council of 
Zimbabwe (MRCZ). Permission to conduct the study at BRIDH was 
obtained from the Director of the Harare City Health Department.
Results
Demographic description of the study 
population 
A total of 97 participants who were both sputum positive for AFB 
and HIV positive were recruited into the study, 59 (61%) being 
females (Table I). The overall mean age was 34 years (SD 8 years). The 
females were younger (mean age 32 (SD 7) years) than the males (36 
(SD 9) years). A quarter of the participants were widowed. The mean 
number of years of formal education was 10 (SD 2) years.
Clinical and laboratory characteristics of the 
study population
The baseline clinical characteristics (Table II) showed an overall 
mean BMI of 18.7 (SD 2.6), with the mean for the males BMI 18.7 
(SD 2.3) and that for the females 18.7 (SD 2.9). The mean KPS score 
was 54.4% (SD 11.9%). Baseline CD4 counts were available for 96 
participants, and of these 69 (72%) had a CD4 count of less than 200 
cells/µl. The median CD4 count was 104.5 cells/µl (1st quartile 41; 
3rd quartile 13). The overall mean haemoglobin concentration was 
9.4 (SD 2.1) g/dl.
Having a low haemoglobin concentration (<8 g/dl), a low BMI 
(<18) and a low KPS score (<54.4%) were found to be predictive of 
having a low CD4+ cell count (<200 cells/µl), with ORs of 13, 3.8 
and 3, respectively (Table III). Bivariate analysis using a clinically 
significant KPS score cut-off of 50% and a CD4 cell count above 
or below 200 cells/µl did not show statistical significance. All 
participants with a KPS score of less than 50% had a CD4 cell count 
of less than 200 cells/µl. Patients with pleuritic  pain were less likely 
than those who did not to have a CD4+ cell count less than 200 cells/
µl (OR 0.2; CI 0.03 - 0.8; p=0.01).
The overall multiple logistic regression model showed that 
a significant variation in CD4 cell count was explained by the 
haemoglobin concentration, BMI and KPS score (p=0.0004). In 
this model, only haemoglobin remained significantly related to low 
CD4 cell count (p=0.01). KPS score and BMI were individually not 
significantly related to CD4 cell count (p=0.5 and 0.1, respectively).
Discussion
In resource-limited hospitals like most district hospitals in Zimbabwe, 
where CD4 machines and other complicated diagnostic equipment 
are not available, good clinical acumen is required to predict which 
patients are likely to have a low CD4 count (<200 cells/µl) and 
therefore need early initiation of ART. 
The demographic characteristics of the participants, of whom  61% 
were women, compare well with the general population of people 
living with HIV/AIDS seeking other Zimbabwean public-sector ART 
services, of whom two-thirds are women.6 HIV/TB co-infection has 
been shown to be associated with significant weight loss.7,8  The BMI 
was used as an indicator of the nutritional status of the participants. 
Although the males were heavier and taller than the females, the 
mean BMI was the same for both sexes. The overall mean BMI 
(18.7 (SD 2.6)) was just above the lower limit of the normal range 
(18 - 25). A BMI of <18 was found to be a significant predictor of a 
low CD4 count. Apart from suggesting severe immunosuppression, 
these results imply that nutritional support should form part of the 
comprehensive package of care of HIV-infected TB patients. 
Studies have shown that HIV-infected TB patients are more likely 
to present for the first time with moderate or severe illness.7,8 We 
used the KPS score to quantify the degree of disease progression at 
the first visit to the hospital. The mean KPS score was low (54.4%) 
at enrolment. A KPS score of 60% refers to requiring occasional 
assistance but being able to care for most of one’s needs, whereas a 
score of 50% refers to requiring considerable assistance and frequent 
medical care. The data were therefore analysed using a clinically 
relevant KPS cut-off point of 50%. This KPS score (<50%) was 
chosen as it is also easy to operationalise at a health care level setting. 
Although statistical significance could not be established (Table III) 
because there was no participant with both a low KPS score (<50%) 
and a CD4 cell count >200 cells/µl, we can safely conclude that a 
KPS score <50% is predictive of a low CD4 count (<200 cells/µl) in 
HIV-infected patients with PTB.9 HIV-positive patients who present 
with PTB and a low KPS score (<50%) should therefore be started 
on ART early. 
It has been noted that people with advanced HIV commonly 
suffer from anaemia because of their inability to produce adequate 
levels of erythropoietin. Anaemia has been shown to be  associated 
with high mortality, as it appears to be an indicator of advanced 
Table I. Baseline demographic characteristics of the 
participants (N=97)
Variable      N
Mean age (yrs) (mean (SD))
Overall      34 (8)
Females     32 (7)
Males     36 (9)
Gender (N (%))
Female     59 (61)
Male     38 (39)
Marital status (N (%))
Single     16 (17)
Married     45 (46)
Divorced    12 (12)
Widowed    24 (25)
Formal education (yrs) (mean (SD))  10 (2)
Table II. Baseline clinical and laboratory characteristics of the 
study participants
Variable 
Weight (kg) (mean (CI))
Males    55.7 (47.9 - 63.5)
Females    50 (42 - 58)
Height (m) (mean (CI))
Males    1.73 (1.65 - 1.81)
Females    1.64 (1.58 - 1.70)
Body mass index (mean (CI))
Overall    18.7 (18.2 - 19.2)
Males    18.7 (17.9 - 19.5)
Females    18.7 (17.9 - 19.5)
Karnofsky Performance   54.4 (52 - 56.8)
Status score (%) (mean (CI))
Haemoglobin (g/dl) (mean (CI))  9.4 (8.9 - 9.8)
CD4 count (cells/µl) (median (IQR)) 104.5 (41 - 213)
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HIV disease.10 In our study, HIV-positive PTB patients with a 
haemoglobin concentration of <8 g/dl had a low CD4 count (OR 
13; CI 1.8 - 533).  This wide CI is likely to have resulted from the 
small sample size following stratification of the haemoglobin data. 
The above finding implies that any HIV-positive pulmonary TB 
patient with a haemoglobin concentration <8 g/dl should be started 
on ART. 
Although the overall multiple logistic regression model including 
haemoglobin, BMI and KPS score as the explanatory variables was 
significant (p=0.002), the haemoglobin concentration was the only 
variable (p=0.01) that remained significantly related to the low CD4 
count.
Chest pain is commonly present in HIV-infected TB patients.5 The 
presence of pleuritic pain was significantly associated with a higher 
CD4 count (>200 cells/µl), and this is in keeping with the World 
Health Organization recommendation that initiation of ART can be 
deferred in patients with TB adenitis and pleural disease as long as 
there is good response to TB therapy.11
HIV-infected PTB patients presenting with a BMI <18, a KPS score 
<50% and a haemoglobin concentration <8 g/dl merit early initiation 
of ART. These results suggest that clinicians in resource-limited 
settings can identify HIV-infected PTB patients who will need to be 
started on ART early using a clinical assessment alone without the 
aid of a CD4 cell count result. These findings should assist clinicians 
to prioritise as well as to scale up the provision of ART in resource-
limited settings where TB is generally widely prevalent.
The study had the following limitations: we enrolled only smear-
positive PTB participants in an urban tertiary-level facility, where 
patients have relatively easy access to care. The study participants 
therefore comprised a highly selected population and may not be 
representative of all PTB/HIV co-infected patients.
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LIVE LAPAROSCOPIC PAEDIATRIC WORKSHOP
12 - 14 NOVEMBER 2010
The Division of Paediatric Surgery, University of the Witwatersrand, will be hosting a Live Laparoscopic Paediatric 
Workshop at Chris Hani Baragwanath Hospital on 12 - 14 November 2010.  The international expert will be Dr 
Joe Curry, lead paediatric surgeon at Great Ormond Street Hospital, London.
In addition to the surgical programme a free paper session will be held on Sunday 14 November, from which a 
dedicated issue of the SA Journal of Surgery will be published in 2011.
